JPWO2021111142A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021111142A5
JPWO2021111142A5 JP2022533459A JP2022533459A JPWO2021111142A5 JP WO2021111142 A5 JPWO2021111142 A5 JP WO2021111142A5 JP 2022533459 A JP2022533459 A JP 2022533459A JP 2022533459 A JP2022533459 A JP 2022533459A JP WO2021111142 A5 JPWO2021111142 A5 JP WO2021111142A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
crystalline form
species
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022533459A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505227A (ja
Publication date
Priority claimed from GBGB1917867.2A external-priority patent/GB201917867D0/en
Application filed filed Critical
Publication of JP2023505227A publication Critical patent/JP2023505227A/ja
Publication of JPWO2021111142A5 publication Critical patent/JPWO2021111142A5/ja
Pending legal-status Critical Current

Links

JP2022533459A 2019-12-06 2020-12-04 トリアゾール抗真菌化合物pc945の多形 Pending JP2023505227A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1917867.2 2019-12-06
GBGB1917867.2A GB201917867D0 (en) 2019-12-06 2019-12-06 Polymorphs
PCT/GB2020/053107 WO2021111142A1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945

Publications (2)

Publication Number Publication Date
JP2023505227A JP2023505227A (ja) 2023-02-08
JPWO2021111142A5 true JPWO2021111142A5 (enExample) 2023-12-13

Family

ID=69171938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533459A Pending JP2023505227A (ja) 2019-12-06 2020-12-04 トリアゾール抗真菌化合物pc945の多形

Country Status (26)

Country Link
US (1) US12491182B2 (enExample)
EP (2) EP4069690B1 (enExample)
JP (1) JP2023505227A (enExample)
KR (1) KR20220110726A (enExample)
CN (1) CN114746415B (enExample)
AU (1) AU2020397613A1 (enExample)
BR (1) BR112022006259A2 (enExample)
CA (1) CA3155829A1 (enExample)
CL (1) CL2022001464A1 (enExample)
CO (1) CO2022007808A2 (enExample)
DK (1) DK4069690T3 (enExample)
ES (1) ES3000984T3 (enExample)
FI (1) FI4069690T3 (enExample)
GB (1) GB201917867D0 (enExample)
HR (1) HRP20250042T1 (enExample)
HU (1) HUE069799T2 (enExample)
IL (1) IL293401A (enExample)
LT (1) LT4069690T (enExample)
MX (1) MX2022006654A (enExample)
PL (1) PL4069690T3 (enExample)
PT (1) PT4069690T (enExample)
RS (1) RS66401B1 (enExample)
SA (1) SA522432879B1 (enExample)
SI (1) SI4069690T1 (enExample)
SM (1) SMT202400514T1 (enExample)
WO (1) WO2021111142A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6669751B2 (ja) 2014-12-05 2020-03-18 プルモシデ リミテド 抗真菌化合物
CN117510488B (zh) * 2022-07-28 2025-12-05 博瑞制药(苏州)有限公司 一种硫酸艾沙康唑的制备方法
CN117330660A (zh) * 2023-09-14 2024-01-02 广州医科大学附属第一医院(广州呼吸中心) Uplc-ms/ms联用检测艾沙康唑的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
EP0318214B1 (en) 1987-11-20 1994-12-14 Schering Corporation Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
HU225062B1 (en) 1993-12-21 2006-05-29 Schering Corp Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
CZ59497A3 (en) 1995-06-02 1997-08-13 Schering Corp Tetrahydrofuran derivative and pharmaceutical composition containing thereof
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
EP1372394A1 (en) 2001-04-03 2004-01-02 Schering Corporation Antifungal composition with enhanced bioavailability
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US9346791B2 (en) 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
JP6669751B2 (ja) 2014-12-05 2020-03-18 プルモシデ リミテド 抗真菌化合物

Similar Documents

Publication Publication Date Title
JP2017536382A5 (enExample)
US6407129B1 (en) Azole compounds, their production and their use
JP2011500779A5 (enExample)
JP2017536385A5 (enExample)
FI4069690T3 (fi) Triatsolisienilääkeyhdiste pc945:n polymorfeja
CN107001343B (zh) 抗真菌的化合物
JP2017536371A5 (enExample)
JPH11228548A (ja) アゾール化合物、その製造法および用途
US8147852B2 (en) Modified azole compounds as antifungal and antibacterial agents
JP2007534764A5 (enExample)
JPWO2021111142A5 (enExample)
EP3060549B1 (en) Novel antifungal oxodihydropyridinecarbohydrazide derivative
AP1379A (en) 2,4,4-Trisubstituted-1,3-dioxolane antifungals.
EP2027850A1 (en) Pharmaceutical compositions containing voriconazole
US6583164B1 (en) Antimycotic drug composition
CA2986854C (en) Dosing regimens for the treatment of fungal infections
JP2000169372A (ja) 抗真菌薬組成物
WO2019106571A1 (en) Dosing regimens for the treatment of fungal infections
US11944609B1 (en) Antifungal ionic liquid and Amphotericin B combination
EA048470B1 (ru) Полиморфы триазольного противогрибкового соединения pc945
WO2007012967A2 (en) Combination of voriconazole and fluconazole
WO2005092884A1 (en) Novel crystalline forms of conazoles and methods of making and using the same
AU2017268504A1 (en) Dosing regimens for the treatment of fungal infections
JPWO2000018401A1 (ja) 抗真菌薬組成物
HK1097756A (en) Combination of voriconazole and an antifungal cyp2c19 inhibitor